Article
Niche-level immune evasion in <i>TP53</i> mutant AML residual disease revealed by spatial proteomics
2026-05-19
Abstract excerpt
<h4>ABSTRACT</h4> Measurable (or minimal) residual disease (MRD) predicts relapse in patients with acute myeloid leukemia (AML). However, the biological and spatial characteristics of the AML bone marrow (BM) microenvironment (BMME) in which MRD cells survive remain largely unexplored; in particular, little is known of the BMME in TP53 mutant ( TP53 mut ) AML. Here, we applied sequential immunofluorescence to w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- aae93cd6-1e16-554f-8bd3-816d13f97294
- DOI
- 10.64898/2026.05.15.725421
